• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Introduction to 5-Nitro-1H-benzodimidazole-2-carboxylic acid (CAS No. 73903-18-1) and Its Emerging Applications in Chemical Biology

5-Nitro-1H-benzodimidazole-2-carboxylic acid, identified by the Chemical Abstracts Service registry number 73903-18-1, is a heterocyclic compound that has garnered significant attention in the field of chemical biology due to its unique structural and pharmacological properties. This compound belongs to the benzodimidazole class, which is known for its broad spectrum of biological activities, including antimicrobial, antiviral, and anticancer effects. The introduction of a nitro group at the 5-position enhances its reactivity and potential therapeutic applications, making it a valuable scaffold for drug discovery and medicinal chemistry research.

The structure of 5-Nitro-1H-benzodimidazole-2-carboxylic acid features a nitro-substituted benzodimidazole core, which contributes to its distinct electronic and steric properties. This structural motif allows for interactions with various biological targets, including enzymes and nucleic acids. The carboxylic acid functionality at the 2-position provides a site for further chemical modification, enabling the synthesis of derivatives with tailored biological activities. Such modifications are crucial for optimizing drug-like properties such as solubility, bioavailability, and target specificity.

In recent years, 5-Nitro-1H-benzodimidazole-2-carboxylic acid has been extensively studied for its potential in addressing complex diseases. One of the most promising areas of research is its application in oncology. Studies have demonstrated that nitro-substituted benzodimidazoles can exhibit inhibitory effects on key enzymes involved in cancer cell proliferation and survival. For instance, research has shown that derivatives of this compound can interfere with the activity of kinases and other signaling molecules that are aberrantly activated in tumor cells. These findings have opened up new avenues for developing novel anticancer agents.

Furthermore, the pharmacological profile of 5-Nitro-1H-benzodimidazole-2-carboxylic acid has been explored in the context of antimicrobial resistance. The nitro group enhances the compound's ability to disrupt bacterial cell wall synthesis and DNA replication, making it effective against both Gram-positive and Gram-negative bacteria. This is particularly relevant in light of the growing crisis posed by multidrug-resistant pathogens. Preclinical studies have indicated that this compound exhibits potent activity against several bacterial strains, including those resistant to conventional antibiotics. Such findings underscore its potential as a lead compound for developing new antibiotics.

The synthetic chemistry of 5-Nitro-1H-benzodimidazole-2-carboxylic acid has also been a focus of interest. Researchers have developed efficient synthetic routes that allow for scalable production of this compound. These methods often involve multi-step reactions starting from commercially available precursors, such as benzodiazole derivatives. The introduction of the nitro group is typically achieved through nitration reactions, which can be performed under controlled conditions to ensure high yield and purity. The synthesis of this compound has been optimized to facilitate further derivatization, enabling rapid screening of analogs with improved pharmacological properties.

Advances in computational chemistry have further enhanced the understanding of 5-Nitro-1H-benzodimidazole-2-carboxylic acid's interactions with biological targets. Molecular modeling studies have provided insights into how this compound binds to its receptors and enzymes, helping to rationalize its biological activity. These computational approaches have been instrumental in guiding the design of novel derivatives with enhanced binding affinity and selectivity. By integrating experimental data with computational predictions, researchers can accelerate the discovery process and identify promising candidates for clinical development.

The biological evaluation of 5-Nitro-1H-benzodimidazole-2-carboxylic acid has revealed several interesting properties beyond its primary pharmacological effects. For example, studies have shown that this compound can modulate inflammatory pathways by interacting with specific transcription factors. This suggests potential applications in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. Additionally, preliminary evidence indicates that it may have neuroprotective effects, making it a candidate for investigating neurodegenerative disorders like Alzheimer's disease.

In conclusion, 5-Nitro-1H-benzodimidazole-2-carboxylic acid (CAS No. 73903-18-1) represents a promising scaffold for drug discovery with diverse applications in chemical biology and medicine. Its unique structural features enable interactions with multiple biological targets, making it a versatile tool for developing novel therapeutic agents. Ongoing research continues to uncover new aspects of its pharmacology and synthetic utility, reinforcing its significance as a valuable compound in medicinal chemistry.

• 89843-46-9(1H-Benzimidazole, 2-methyl-6-nitro-)
• 2735-57-1(1-(6-nitro-1H-benzimidazol-2-yl)-Ethanone)
• 1792-40-1(2-methyl-5-nitro-1H-1,3-benzodiazole)
• 170648-89-2(1H-Benzimidazole-2-methanol, 4-nitro-)
• 372953-13-4(5-amino-1H-1,3-benzodiazole-2-carboxylic acid)
• 29039-60-9(5-Nitro-1H-benzoimidazole-2-carboxylic acid ethylester)
• 20034-00-8((5-nitro-1H-1,3-benzodiazol-2-yl)methanol)
• 189045-24-7(1H-Benzimidazole-2-carboxylicacid, 7-nitro-)
• 20033-95-8(1-(5-nitro-1H-1,3-benzodiazol-2-yl)ethan-1-ol)
• 93521-65-4(Methyl 5-Nitro-1H-benzodimidazole-2-carboxylate)